MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression

Molecular Cancer Research

Volumn 9, Issue 8, 2011, Pages 1100-1111

  Wang, Yemin ^a   Huang, Jen Wei ^a   Li, Ming ^b   Cavenee, Webster K ^b   Mitchell, Patrick S ^a   Zhou, Xiaofeng ^c   Tewari, Muneesh ^a   Furnari, Frank B ^b   Taniguchi, Toshiyasu ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CISPLATIN; HISTONE H2AX; MICRORNA; MICRORNA 138; OLAPARIB; PACLITAXEL; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; MOLECULAR LIBRARY; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING;

CAMPTOTHECIN; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HELA CELLS; HUMANS; MICRORNAS; NEOPLASMS; NUCLEAR PROTEINS; RADIATION, IONIZING; STRESS, PHYSIOLOGICAL;

EID: 80051975920     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-11-0007     Document Type: Article

References (49)

1. Zhou B.B., Elledge S.J. The DNA damage response: Putting checkpoints in perspective. Nature 2000;408:433-439
2. Löbrich M., Shibata A., Beucher A., Fisher A., Ensminger M., Goodarzi A.A., et al. gamma H2AX foci analysis for monitoring DNA double-strand break repair: Strengths, limitations and optimization. Cell Cycle 2010;9:662-669
3. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA doublestranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-5868 (Pubitemid 28124064)
4. Dickey J.S., Redon C.E., Nakamura A.J., Baird B.J., Sedelnikova O.A., Bonner W.M. H2AX: Functional roles and potential applications. Chromosoma 2009;118:683-692
5. Stucki M., Clapperton J.A., Mohammad D., Yaffe M.B., Smerdon S.J., Jackson S.P. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005;123:1213-1226 (Pubitemid 41821780)
6. Lukas C., Melander F., Stucki M., Falck J., Bekker-Jensen S., Goldberg M., et al. Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. Embo J 2004;23:2674-2683 (Pubitemid 38988238)
7. Lou Z., Minter-Dykhouse K., Franco S., Gostissa M., Rivera M.A., Celeste A., et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell 2006;21:187-200. (Pubitemid 43099935)
8. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 1999;146:905-916
9. Bassing C.H., Chua K.F., Sekiguchi J., Suh H., Whitlow S.R., Fleming J.C., et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci U S A 2002;99:8173-8178 (Pubitemid 34651025)
10. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., et al. Genomic instability in mice lacking histone H2AX. Science 2002;296:922-927 (Pubitemid 34464900)
11. Bartel D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297
12. Trang P., Weidhaas J.B., Slack F.J. MicroRNAs as potential cancer therapeutics. Oncogene 2008;27 Suppl 2:S52-S57
13. Shenouda S.K., Alahari S.K. MicroRNA function in cancer: Oncogene or a tumor suppressor? Cancer Metastasis Rev 2009;28:369-378
14. Lal A., Pan Y., Navarro F., Dykxhoorn D.M., Moreau L., Meire E., et al. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 2009;16:492-498
15. Hu H., Du L., Nagabayashi G., Seeger R.C., Gatti R.A. ATM is downregulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci U S A 2010;107:1506-1511
16. Pothof J., Verkaik NS, van IW, Wiemer EA, Ta VT, van der Horst GT, et al. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J 2009;28:2090-2099
17. Zhang X., Wan G., Mlotshwa S., Vance V., Berger F.G., Chen H., et al. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res 2010;70:7176-7186
18. Sakai W., Swisher E.M., Karlan B.Y., Agarwal M.K., Higgins J., Friedman C., et al. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 2008;451:1116-1120 (Pubitemid 351317449)
19. Li S., Kuhne W.W., Kulharya A., Hudson F.Z., Ha K., Cao Z., et al. Involvement of p54(nrb), a PSF partner protein, in DNA double-strand break repair and radioresistance. Nucleic Acids Res 2009;37:6746-6753
20. Weinstock D.M., Nakanishi K., Helgadottir H.R., Jasin M. Assaying double-strand break repair pathway choice in mammalian cells using a targeted endonuclease or the RAG recombinase. Methods Enzymol 2006;409:524-540
21. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 2002;109:459-472 (Pubitemid 34564473)
22. Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Lobrich M., Jeggo P.A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 2004;64:2390-2396 (Pubitemid 38523891)
23. Obernosterer G., Leuschner P.J., Alenius M., Martinez J. Post-transcriptional regulation of microRNA expression. RNA 2006;12:1161-1167 (Pubitemid 43990541)
24. Xie A., Puget N., Shim I., Odate S., Jarzyna I., Bassing C.H., et al. Control of sister chromatid recombination by histone H2AX. Mol Cell 2004;16:1017-1025 (Pubitemid 40018410)
25. Liang F., Romanienko P.J., Weaver D.T., Jeggo P.A., Jasin M. Chromosomal double-strand break repair in Ku80-deficient cells. Proc Natl Acad Sci U S A 1996;93:8929-8933 (Pubitemid 26281994)
26. Moynahan M.E. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 2002;21:8994-9007. (Pubitemid 36110828)
27. Yuan J., Chen J. MRE11-RAD50-NBS1 complex dictates DNA repair independent of H2AX. J Biol Chem 2010;285:1097-1104
28. Raschle M., Knipscheer P., Enoiu M., Angelov T., Sun J., Griffith J.D., et al. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell 2008;134:969-980
29. Bryant H.E., Helleday T. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucleic Acids Res 2006;34:1685-1691
30. Lord C.J., McDonald S., Swift S., Turner N.C., Ashworth A. A highthroughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity. DNA Repair (Amst)2008;7:2010-2019
31. Horwitz S.B. Mechanism of action of taxol. Trends Pharmacol Sci 1992;13:134-136
32. Liu H., Kohane I.S. Tissue and process specific microRNA-mRNA coexpression in mammalian development and malignancy. PLoS One 2009;4:e5436.
33. Crosby M.E., Kulshreshtha R., Ivan M., Glazer P.M. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 2009;69:1221-1229
34. Weidhaas J.B., Babar I., Nallur S.M., Trang P., Roush S., Boehm M., et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007;67:11111-11116 (Pubitemid 350248533)
35. Cha H.J., Shin S., Yoo H., Lee E.M., Bae S., Yang K.H., et al. Identification of ionizing radiation-responsive microRNAs in the IM9 human B lymphoblastic cell line. Int J Oncol 2009;34:1661-1668
36. Shin S., Cha H.J., Lee E.M., Lee S.J., Seo S.K., Jin H.O., et al. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int J Oncol 2009;35:81-86
37. Zhao X., Yang L., Hu J., Ruan J. miR-138 might reverse multidrug resistance of leukemia cells. Leuk Res 2010;34:1078-1082
38. Morton S.U., Scherz P.J., Cordes K.R., Ivey K.N., Stainier D.Y., Srivastava D. microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci U S A 2008;105:17830-17835
39. Siegel G., Obernosterer G., Fiore R., Oehmen M., Bicker S., Christensen M., et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 2009;11:705-716
40. Yang Z., Bian C., Zhou H., Huang S., Wang S., Liao L., et al. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through EID-1. Stem Cells Dev 2010;20:259-267
41. Ko J.Y., Lee T.C., Hsiao C.F., Lin G.L., Yen S.H., Chen K.Y., et al. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma. Cancer 2002;94:1987-1996 (Pubitemid 34270052)
42. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101:2999-3004. (Pubitemid 38327724)
43. Mitomo S., Maesawa C., Ogasawara S., Iwaya T., Shibazaki M., Yashima-Abo A., et al. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 2008;99:280-286 (Pubitemid 351228481)
44. Liu X., Jiang L., Wang A., Yu J., Shi F., Zhou X. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 2009;286:217-222
45. Jiang L., Liu X., Kolokythas A., Yu J., Wang A., Heidbreder C.E., et al. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 2010;127:505-512
46. Ding J., Huang S., Wu S., Zhao Y., Liang L., Yan M., et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 2010;12:390-399
47. Celeste A., Difilippantonio S., Difilippantonio M.J., Fernandez-Capetillo O., Pilch D.R., Sedelnikova O.A., et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003;114:371-383 (Pubitemid 36962935)
48. Bader A.G., Brown D., Winkler M. The promise of microRNA replacement therapy. Cancer Res 2010;70:7027-7030
49. Petrocca F., Lieberman J. Promise and challenge of RNA interference-based therapy for cancer. J Clin Oncol 2011;29:747-754